Challenges and solutions in developing new medications for Schizophrenia.
Of the 24 million people with schizophrenia worldwide, fewer than 50% receive appropriate care.¹ Even patients with access to the best available treatments suffer from significant functional and social deficits.² This article is based on a teleconference that discussed issues related to the development of new treatments for schizophrenia.
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D016503:Drug Delivery Systems / Q000379:methods*; D055808:Drug Discovery / Q000379:methods*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy*; D013685:Telecommunications
D014150:Antipsychotic Agents; D015507:Drugs, Investigational